Assertio Therapeutics News

October 04, 2019

Assertio Therapeutics News

Assertio currently markets two FDA-approved products and continues to identify license and develop new products that offer enhanced options for patients that may be under. ASRT stock news and headlines to help you in your trading and investing decisions.

Assertio Therapeutics A Biotech Stock Trading Below Its Cash Balance Nasdaq Asrt Seeking Alpha

ASRT stock quote history news and other vital information to help you with your stock trading and investing.

Assertio therapeutics news. Depomed was founded in 1995 and is headquartered in Newark California. It is a publicly traded company on NASDAQ with several products approved by the United States Food and Drug. It mainly markets products for treatment in neurology pain and diseases of the central nervous system.

Contact Us 100 South Saunders Road Suite 300 Lake Forest IL 60045 Tel. Applied Pharma Research Licensed the drug delivery technology and intellectual property to Cambia diclofenac potassium for oral solution from APR and collaborated to formulate a new life cycle extension. LAKE FOREST Ill May 20 2020 PRNewswire -- Assertio Holdings Inc the successor issuer to Assertio Therapeutics Inc Assertio NASDAQ.

Find the latest Assertio Holdings Inc. ASRT announced the closing of the merger with Zyla Life Sciences. The Investor Relations website contains information about Assertio Therapeutics Incs business for stockholders potential investors and financial analysts.

Formerly Depomed Inc is an American specialty pharmaceutical company. To Report First Quarter 2021 Financial Results After the Close of Markets on Thursday May 6 2021More News March 11 2021 Assertio Reports Fourth Quarter and Full Year 2020 Financial Results More News. Get a real-time Assertio Therapeutics ASRT stock price quote with breaking news financials statistics charts and more.

Heres a roundup of top developments. Assertio Therapeutics is committed to providing responsible solutions to advance patient care in the Companys core areas of neurology orphan and specialty medicines. Assertio Therapeutics is committed to providing responsible solutions to advance patient care in the Companys core areas of neurology orphan and specialty medicines.

ASRT today announced that it will release fourth quarter and full year 2020 financial results on Thursday March 11 2021 after. View real-time stock prices and stock quotes for a full financial overview. 18 2021 GLOBE NEWSWIRE -- Assertio Holdings Inc.

ASRT Complete Assertio Holdings Inc. 06 2020 Assertio Holdings Inc. He served as chief operating officer and chief financial officer CFO at EKR Therapeutics Inc a privately held specialty pharmaceutical company from 2010 until EKR was sold to Cornerstone Therapeutics Inc.

To Report Fourth Quarter and Full Year 2020 Financial Results After the Close of Markets on Thursday March 11 2021 LAKE FOREST Ill. Assertio currently markets three FDA-approved products and continues to identify license and develop new products that offer enhanced options for patients that may be underserved by existing therapies. Get the latest Assertio Holdings Inc.

The combined company the Company will operate under the Assertio name and trade on Nasdaq under the ticker ASRT. Stock news by MarketWatch. The Daily Biotech Pulse.

SEC Filing - Quarterly Report 10-Q August 10 2020. Assertio is experienced in forming and managing a variety of innovative partnerships and deal structures. McKee has served as director of Assertio since March 2017.

Lilly COVID-19 Antibody Cocktail Approved for Emergency Use Gamida Genfit Jump On Data 2 IPOs 1234pm Wednesday 10th Feb 2021. Assertio Therapeutics is committed to providing responsible solutions to advance patient care in the Companys core areas of neurology orphan and specialty medicines. Assertio Therapeutics EPS misses by 005 beats on revenue SA News Fri Nov.

7 rijen Opens in a new window Opens an external site Opens an external site in a new window. Assertio or the Company NASDAQ. Real time Assertio Therapeutics Inc ASRT stock price quote stock graph news analysis.

Assertio Completed Merger With Zyla Life Sciences